TY - CHAP
T1 - Characterization of Islet Preparations
AU - Colton, Clark K.
AU - Papas, Klearchos K.
AU - Pisania, Anna
AU - Rappel, Michael J.
AU - Powers, Daryl E.
AU - O'Neil, Joh J.
AU - Omer, Abdulkadir
AU - Weir, Gordon
AU - Bonner-Weir, Susan
N1 - Funding Information:
This study was supported by grants from the NIH (NCRR ICR U4Z RR 16606 and R01-DK063108-01A1), the JDRF Center for Islet Transplantation at Harvard Medical School, the Diabetes Research and Wellness Foundation, and an important group of private donors. Technical assistance was also provided by the Diabetes and Endocrinology Research Center (DERC) of the Joslin Diabetes Center supported by the NIH (P30 DK36836-16).
PY - 2007
Y1 - 2007
N2 - To move forward in the development of improved methods in Islet transplantation, it is essential to have assays to assess meaningful characteristics of islet preparations. This chapter examines the methods for in vitro characterization of islet preparations. Methods can be divided into three groups: islet purity and composition, quantity of islets, and viability of islets. Light microscopic observation following staining with dithizone (diphenylthiocarbazone, DTZ) is the commonly accepted technique employed currently to assess the purity of islet preparations. Because of its inadequacies, a variety of new techniques have been evolved, such as immunohistochemistry using laser scanning, confocal microscope, and ultrastructural analysis using electron microscope. The methods for measuring the quantity of islets in an islet preparation include DTZ staining large particle flow cytometry and tissue pellet packed cell volume ultrasound scattering. Membrane integrity measurement by visual assessment following staining with fluorescein diacetate and propidium iodide is the most commonly employed method of assessing fractional viability of islet preparations. It also reviews assays currently in use, as well as new methods under study at various laboratories with special attention to the own efforts. In examining these methods, discussion provides attention to utility in terms of adequacy for the intended purpose, accuracy and precision, time required to perform the assay and obtain a result, and cost in terms of materials and equipment.
AB - To move forward in the development of improved methods in Islet transplantation, it is essential to have assays to assess meaningful characteristics of islet preparations. This chapter examines the methods for in vitro characterization of islet preparations. Methods can be divided into three groups: islet purity and composition, quantity of islets, and viability of islets. Light microscopic observation following staining with dithizone (diphenylthiocarbazone, DTZ) is the commonly accepted technique employed currently to assess the purity of islet preparations. Because of its inadequacies, a variety of new techniques have been evolved, such as immunohistochemistry using laser scanning, confocal microscope, and ultrastructural analysis using electron microscope. The methods for measuring the quantity of islets in an islet preparation include DTZ staining large particle flow cytometry and tissue pellet packed cell volume ultrasound scattering. Membrane integrity measurement by visual assessment following staining with fluorescein diacetate and propidium iodide is the most commonly employed method of assessing fractional viability of islet preparations. It also reviews assays currently in use, as well as new methods under study at various laboratories with special attention to the own efforts. In examining these methods, discussion provides attention to utility in terms of adequacy for the intended purpose, accuracy and precision, time required to perform the assay and obtain a result, and cost in terms of materials and equipment.
UR - http://www.scopus.com/inward/record.url?scp=84882476305&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84882476305&partnerID=8YFLogxK
U2 - 10.1016/B978-012369415-7/50007-7
DO - 10.1016/B978-012369415-7/50007-7
M3 - Chapter
AN - SCOPUS:84882476305
SN - 9780123694157
SP - 85
EP - 133
BT - Cellular Transplantation
PB - Elsevier Inc.
ER -